Ligand validation:1XSK

MPO: 3[N-MORPHOLINO]PROPANE SULFONIC ACID

MPO is a Ligand Of Interest in 1XSK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1XSK_MPO_C_2002	57%	10%	0.146	0.922	2.09	2.23	2	6	0	0	100%	1
1XSK_MPO_E_2004	51%	11%	0.16	0.914	1.92	2.26	2	6	0	0	100%	1
1XSK_MPO_D_2003	50%	11%	0.196	0.946	1.93	2.29	2	6	0	0	100%	1
1XSK_MPO_B_2001	40%	10%	0.172	0.881	1.99	2.28	2	6	0	0	100%	1
1XSI_MPO_C_1002	76%	32%	0.12	0.956	1.39	1.32	1	2	0	0	100%	1
2F2H_MPO_B_3010	72%	22%	0.142	0.968	2.04	1.24	1	2	0	0	100%	1
4MZC_MPO_A_201	100%	63%	0.031	0.998	0.43	0.98	-	1	0	0	100%	1
1KJQ_MPO_A_397	100%	25%	0.042	0.99	1.69	1.37	2	2	0	0	100%	1
1KJ9_MPO_A_400	100%	18%	0.046	0.988	2.1	1.42	2	3	0	0	100%	1
1KJI_MPO_A_398	99%	16%	0.052	0.989	1.99	1.7	2	3	0	0	100%	1
4LRQ_MPO_B_201	99%	9%	0.061	0.99	2.22	2.32	2	7	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.